REPCF
REPLICEL LIFE SCIENCE ORD by RepliCel Life Sciences Inc. (REPCF)
$
00About REPLICEL LIFE SCIENCE ORD by RepliCel Life Sciences Inc. (REPCF)
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
144,500
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
-.95
REPLICEL LIFE SCIENCE ORD by RepliCel Life Sciences Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
144,500
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
-.95